117 related articles for article (PubMed ID: 3720782)
1. Domiciliary chemotherapy for malignant disease.
Malone J; Kavanagh J; Crosson K; Streckfuss B
Eur J Gynaecol Oncol; 1986; 7(2):120-1. PubMed ID: 3720782
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy for gynecologic malignancies at Siriraj Hospital, Bangkok.
Senapad S
Southeast Asian J Trop Med Public Health; 1985 Dec; 16(4):656-9. PubMed ID: 3939044
[No Abstract] [Full Text] [Related]
3. [Ambulatory use of cisplatin. Preliminary considerations].
de Oliveira Filho JA; da Cunha FM
Rev Paul Med; 1983; 101(5):199-202. PubMed ID: 6200911
[No Abstract] [Full Text] [Related]
4. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025
[TBL] [Abstract][Full Text] [Related]
5. Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration.
Hainsworth JD; Grosh WW; Burnett LS; Jones HW; Wolff SN; Greco FA
Ann Intern Med; 1988 Feb; 108(2):165-70. PubMed ID: 3124679
[TBL] [Abstract][Full Text] [Related]
6. Aztreonam plus piperacillin--empiric treatment of neutropenic fever in gynecology-oncology patients receiving cisplatin-based chemotherapy.
Fishman A; Chowers M; Altaras M; Beyth Y; Lang R
Eur J Gynaecol Oncol; 1998; 19(2):126-9. PubMed ID: 9611050
[TBL] [Abstract][Full Text] [Related]
7. Phase I trial of escalating doses of paclitaxel combined with fixed doses of cisplatin and doxorubicin in advanced endometrial cancer and other gynecologic malignancies: a Gynecologic Oncology Group study.
Fleming GF; Fowler JM; Waggoner SE; Copeland LJ; Greer BE; Horowitz I; Sutton G; Schilder RJ; Fracasso PM; Ball HG; McGuire WP
J Clin Oncol; 2001 Feb; 19(4):1021-9. PubMed ID: 11181665
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Anand A; Anand A; Anand N
Cancer; 1996 May; 77(9):1959-60. PubMed ID: 8646700
[No Abstract] [Full Text] [Related]
9. Cyclophosphamide, hexamethylmelamine, adriamycin and cisplatin combination chemotherapy in mixed mesodermal sarcoma of the female genital tract.
Jansen RL; van der Burg ME; Verweij J; Stoter G
Eur J Cancer Clin Oncol; 1987 Aug; 23(8):1131-3. PubMed ID: 3115787
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporin enhancement of cisplatin chemotherapy in patients with refractory gynecologic cancer. A Gynecologic Oncology Group Study.
Manetta A; Boyle J; Berman ML; DiSaia PJ; Lentz S; Liao SY; Mutch D; Slater L
Cancer; 1994 Jan; 73(1):196-9. PubMed ID: 8275425
[TBL] [Abstract][Full Text] [Related]
11. [Bone marrow suppression in gynecological patients with malignant tumor treated with combination chemotherapy cyclophosphamide, pirarubicin and cisplatin].
Kozaki S; Yanagawa Y; Ueki M; Sugimoto O; Okazaki T; Saeki M; Nomura H; Kanda T; Iwai E; Miyawaki Y
Gan To Kagaku Ryoho; 1990 Jun; 17(6):1189-93. PubMed ID: 2350194
[TBL] [Abstract][Full Text] [Related]
12. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
Oshita F; Kasai T; Kurata T; Fukuda M; Yamamoto N; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin, doxorubicin, cyclophosphamide, and etoposide combination chemotherapy for small-cell lung cancer.
Aisner J; Whitacre MY; Budman DR; Propert K; Strauss G; Van Echo DA; Perry M
Cancer Chemother Pharmacol; 1992; 29(6):435-8. PubMed ID: 1314712
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin, adriamycin and ifosfamide-based combination chemotherapy for gynecological cancers derived from the extended müllerian system.
Nishida T; Nagasue N; Izumi S; Sakihama H; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):193-8. PubMed ID: 1690254
[TBL] [Abstract][Full Text] [Related]
15. High-dose, short-duration cisplatin/doxorubicin combination chemotherapy for advanced ovarian epithelial cancer.
Hunter RE; Griffin TW; Stevens S; Roman LD; Bokhari F; Reale FR; Tak WK; Fitzgerald TJ; Dillon MB; Rose PG
Cancer; 1991 Nov; 68(9):1890-4. PubMed ID: 1655227
[TBL] [Abstract][Full Text] [Related]
16. Increased nephrotoxicity of combination taxol and cisplatin chemotherapy in gynecologic cancers as compared to cisplatin alone.
Merouani A; Davidson SA; Schrier RW
Am J Nephrol; 1997; 17(1):53-8. PubMed ID: 9057954
[TBL] [Abstract][Full Text] [Related]
17. Treatment of gynecological malignancies with a combination of cisplatin, adriamycin and ifosfamide.
Nishida T; Nagasue N; Yakushiji M
Cancer Chemother Pharmacol; 1990; 26 Suppl():S39-42. PubMed ID: 2347048
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell lines.
Xu MJ; Alberts DS; Liu R; Leibovitz A; Liu Y
Cancer Chemother Pharmacol; 1989; 25(2):89-94. PubMed ID: 2598404
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy for advanced gynecological carcinoma with cis-dichlorodiammineplatinum (II), adriamycin and/or cyclophosphamide after failure of initial treatment (author's transl)].
Takizawa K; Matsuzawa M; Takahashi M; So E; Hasumi K; Sampi K
Nihon Gan Chiryo Gakkai Shi; 1981 Oct; 16(6):1292-1302. PubMed ID: 7199554
[No Abstract] [Full Text] [Related]
20. Phase III comparison of cisplatin alone versus cisplatin, doxorubicin and cyclophosphamide in the treatment of bladder (urothelial) cancer: a Southeastern Cancer Study Group trial.
Troner M; Birch R; Omura GA; Williams S
J Urol; 1987 Apr; 137(4):660-2. PubMed ID: 3550148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
